Meanwhile, Kockwelp et al. sought to classify five distinct AML types: CBFB::MYH11, NPM1 mutation, FLT3-ITD mutation, AML with myelodysplastic changes, and a fifth category, favorable risk AML. This evidence concerns the gene MYH11 and acute myeloid leukemia.